Pathology AI (Artificial Intelligence) Market Size to Reach at a Highest CAGR of 16.1% by 2030 | Component, Neural Network, Application, End User, Region, Competitive Landscape, Key Drivers

The Pathology AI (Artificial Intelligence) Market can be defined as the integration of AI-based algorithms and machine learning techniques in the world of pathology. Pathology, a critical discipline in medicine, involves the study of tissues and cells to diagnose diseases, understand their progression, and guide treatment decisions. With the advent of artificial intelligence, this traditional practice is undergoing a profound transformation, supported by advanced computing capabilities that provide pathologists and healthcare providers with unprecedented insights.

The global Pathology AI (Artificial Intelligence) market size was estimated at USD 23.4 million in 2023 and is projected to reach USD 66.53 billion in 2030 at a CAGR of 16.1% during the forecast period 2023-2030. Increasing government initiatives to encourage healthcare providers and other healthcare organizations to adopt AI-based diagnostic technologies, as well as investments by non-profits and private companies for better data sharing, improved clinical outcomes and cost reduction are some of the expected key drivers. to boost the growth of the artificial intelligence pathology market during the forecast period. Additionally, high demand for e-diagnosis services in healthcare due to increasing government healthcare expenditure is fueling the market growth. In addition, the growing need to reduce diagnostic costs, improve patient care and reduce machine downtime is one of the factors accelerating the use of artificial intelligence in pathology and diagnostics.

Request Sample Pages of Report: https://www.delvens.com/get-free-sample/pathology-ai-market-trends-forecast-till-2030

The prominent players in the Pathology AI (Artificial Intelligence) market are General Electric Co. (GE Healthcare), Koninklijke Philips N.V, F. Hoffmann-La Roche Ltd, Hologic, Inc, Akoya Biosciences, Inc, Aiforia, Indica Labs Inc, OptraScan, Ibex Medical Analytics Ltd., Mindpeak GmbH, Tribun Health, Siemens Healthineers, Zebra Medical Vision, Inc., Riverain Technologies, IDx Technologies Inc., NovaSignal Corporation, Vuno, Inc., Aidoc, Neural Analytics, Imagen Technologies, Digital Diagnostics, Inc., GE Healthcare, AliveCor Inc., Proscia Inc, PathAl, Inc., Tempus Labs, Inc., and others.

Pathology AI (Artificial Intelligence) Market Recent Developments:

In April 2023, Indica Labs Inc. signed an agreement with Lunit Inc. The agreement helped to provide a fully interoperable solution between Indica Labs' HALO AP image management software platform and Lunit's suite of AI pathology products.

In March 2022, Ibex Medical Analytics Ltd. Had partnered with Dedalus Group. Through this partnership, the company aimed to bring the power of artificial intelligence to digital pathology.

Delvens Industry Expert's Standpoint

The AI Pathology Market is anticipated to grow as AI technologies continue to evolve, becoming more capable of analyzing and interpreting complex pathological data. The integration of AI into pathology workflows has the potential to revolutionize diagnostic practices, reduce errors, enhance patient outcomes, and pave the way for personalized medicine. It represents a dynamic intersection of cutting-edge technology and the field of medicine, poised to revolutionize the way diseases are diagnosed, characterized, and treated. It has witnessed significant growth in recent years, driven by advancements in artificial intelligence technology, increasing adoption of digital pathology infrastructure, and a growing need for accurate and efficient diagnostic solutions.

Inquire Before Buying: https://www.delvens.com/Inquire-before-buying/pathology-ai-market-trends-forecast-till-2030

Scope of the Report:

The Pathology AI (Artificial Intelligence) Market is segmented into various segments such as component, neural network, application, end user and region:

Based on component, the Pathology AI (Artificial Intelligence) Market is segmented into:

Software
Scanners

Based on the neural network, the Pathology AI (Artificial Intelligence) Market is segmented into:

CNN
GAN
RNN

Based on the application, the Pathology AI (Artificial Intelligence) Market is segmented into:

Drug Discovery
Diagnosis
Prognosis
Workflow
Education

Based on end user, the Pathology AI (Artificial Intelligence) Market is segmented into:

Pharma
Biotech
Hospital Labs
Research

Based on region, the Pathology AI (Artificial Intelligence) Market is segmented into:

Asia Pacific

Japan
China
India
Australia
South Korea
Vietnam
New Zealand
Philippines
Thailand
Malaysia
Hong Kong
Taiwan
Singapore
Indonesia
Sri Lanka
Rest of Asia-Pacific

North America

U.S.
Canada
Mexico

Europe

Germany
U.K.
France
Italy
Spain
Sweden
Austria
Finland
Belgium
Turkey
Russia
Poland
Hungary
Czech Republic
Switzerland
Netherlands
Rest of Europe

South America

Brazil
Argentina
Chile
Colombia
Rest of South America

Middle East & Africa

South Africa
U.A.E.
Saudi Arabia
Oman
Qatar
Iran
Egypt
Rest of Middle East and Africa

North America to Dominate the Market

North America is estimated to account for the largest market share during the forecast period. In North America, there is growing investments and reforms to modernize the pathology infrastructure in the region and the increasing adoption of digital pathology solutions.

Moreover, the expansion of healthcare infrastructure and growing market availability of advanced AI technologies.

Reasons to Acquire:

Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.

Gain authentic and granular data access for the Pathology AI (Artificial Intelligence) Market to understand the trends and the factors involved in changing market situations.

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Direct Purchase of the Pathology AI (Artificial Intelligence) Market Research Report at: https://www.delvens.com/checkout/pathology-ai-market-trends-forecast-till-2030

Contact Us:

UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
SALES@DELVENS.COM
WEBSITE: https://delvens.com/

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

This release was published on openPR.